JULIA NORTON: Open Payments
NPI 1891279154 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$750 in 22 payments from 14 companies in 2025. Trend: 2023 $941 · 2024 $663 · 2025 $750
Food & beverage: $750
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $203 |
| Alnylam Pharmaceuticals Inc. | 2 | $129 |
| BridgeBio Pharma, Inc. | 2 | $96 |
| E.R. Squibb & Sons, L.L.C. | 4 | $82 |
| Medtronic, Inc. | 2 | $36 |
| United Therapeutics Corporation | 1 | $33 |
| PFIZER INC. | 1 | $25 |
| Lilly USA, LLC | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Boston Scientific Corporation | 1 | $23 |
Products named: CARDIOMEMS, AMVUTTRA, Attruby, CAMZYOS, PULSESELECT, Orenitram, VYNDAQEL, ZEPBOUND.
Industry payments across ID — which companies pay providers there.
